REDUCED FUNCTIONALITY AND KINESIOPHOBIA IN PATIENTS WITH HEART FAILURE: USE OF ALTERNATIVE THERAPEUTIC STRATEGIES
NCT07099495 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2025-08-01
Summary
Introduction: Heart failure (HF) is a clinical syndrome that has advanced on a large scale concomitant with population aging and other factors. Thus, the search for alternatives that minimize the losses resulting from its structural and functional damage are important to optimize its treatments, with the primary objective of enabling the participation of these individuals in the most diverse daily tasks. Low-frequency (LF) or medium-frequency (MF) neuromuscular electrical stimulation (NMES) can be considered a resource to enable the improvement of vital and functional parameters of the population with HF intolerant to physical exercise, and it is also important to identify within these modalities which is most effective. In addition to these factors, kinesiophobia can be found in this population, and NMES can also be adopted as a strategy for kinesiophobia in these patients, with the objective of enabling the progression of behaviors. Objective: To evaluate and compare the effectiveness of LF and MF NMES on the indices of kinesiophobia and functionality in patients with HF. Methods: The research will be divided into two types of study: a double-blind randomized clinical trial (RCT) to evaluate NMES protocols, and a qualitative study with subsequent development and validation of a questionnaire to measure kinesiophobia in individuals with HF. The population included in the RCT will have their assessments (personal, socioeconomic, demographic data, Sit-to-Stand Test, kinesiological ultrasound and surface electromyography of the quadriceps muscles) conducted before their discharge from Hospital Nova Esperança (HNE), and after completion of the protocols at the same institution, in the city of João Pessoa - Paraíba. The application of NMES protocols will be carried out in the home environment (30 min/day, 3 times a week, for a total of 8 consecutive weeks). The population for the qualitative study and for the development of the questionnaire will consist of individuals diagnosed with HF of any etiology, compensated and able to perform kinesiotherapy activities, admitted to the HNE wards, between 24-48 hours before hospital discharge. An in-depth semi-structured interview will be conducted with these individuals, followed by the application of questionnaires developed based on the interviews, and the entire study will be conducted while the patients are hospitalized. Expected results: Regarding the first study, it is expected that patients treated with NMES will show improvements in clinical and functional variables, and these improvements may be more pronounced depending on the frequency applied. On the other hand, the qualitative study may reveal whether patients have fear of movement, even if they are clinically stable. The developed questionnaire will be well understood and have adequate psychometric qualities. Finally, it is expected that this knowledge can serve as a basis for optimizing the care of this patient population.
Conditions
- Heart Failure
- Heart Failure NYHA Class III
- Heart Failure NYHA Class IV
- Neuromuscular Electrical Stimulation (NMES)
- Kinesiophobia
Interventions
- DEVICE
-
Low Frequency Neuromuscular Electrical Stimulation
The surface electrodes will be placed on the upper lateral side of the quadriceps, 5 cm below the inguinal fold and 3 cm above the upper edge of the patella of both lower extremities, bilaterally and with a slight flexion of the knees. They will be fixed with bandages or tape, and conductive gel will be used below the electrodes. Each electrically stimulated contraction will have a frequency of 10 Hz, duration of 10 seconds (ON time: 10s), interspersed with a 20-second rest period (OFF time: 20s), with a pulse width of 400 µs. The protocol will last a total of 8 weeks, being performed 3 times a week, with application of the equipment for 30 minutes each day.
- DEVICE
-
Medium Frequency Neuromuscular Electrical Stimulation
The surface electrodes will be placed on the upper lateral side of the quadriceps, 5 cm below the inguinal fold and 3 cm above the upper edge of the patella of both lower extremities, bilaterally and with a slight flexion of the knees. They will be fixed with bandages or adhesive tape, and conductive gel will be used below the electrodes. Each electrically stimulated contraction will have a frequency of 50 Hz, duration of 10 seconds (ON time: 10s), interspersed by a period of 20 seconds of rest (OFF time: 20s), with a pulse width of 400 µs. The protocol will last a total of 8 weeks, being performed 3 times a week, with application of the equipment for 30 minutes each day.
- DEVICE
-
Neuromuscular Electrical Stimulation without generating contractility
The surface electrodes will be placed on the upper lateral side of the quadriceps, 5 cm below the inguinal fold and 3 cm above the upper edge of the patella of both lower extremities, bilaterally and with a slight flexion of the knees. They will be fixed with bandages or adhesive tape, and conductive gel will be used below the electrodes. No muscle contractions will be generated. The protocol will last a total of 8 weeks, being performed 3 times a week, with application of the equipment for 30 minutes each day.
Sponsors & Collaborators
-
Universidade Federal do Rio Grande do Norte
lead OTHER
Principal Investigators
-
Patrícia A de Miranda Silva Nogueira, Doctorate degree (PhD) · Universidade Federal do Rio Grande do Norte
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-18
- Primary Completion
- 2027-06-30
- Completion
- 2027-12-30
Countries
- Brazil
Study Locations
More Related Trials
-
The Effect of Low LEVel TrAgus STimulation on the Electrophysiological Substrate of Patients With Ischemic CardioMyopathy Substrate of Subjects With Ischemic CardioMyopathy
NCT03549468 ·Status: COMPLETED ·Phase: NA
-
Conduction System Pacing Versus Biventricular Resynchronization in Patients With Chronic Heart Failure
NCT05572736 ·Status: COMPLETED ·Phase: NA
-
The Relationship Between Left Atrial Pressure and Cardiac Function After Atrioventricular Node Ablation
NCT05449158 ·Status: COMPLETED ·Phase: NA
-
Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction
NCT02115230 ·Status: UNKNOWN ·Phase: NA
-
Effects of Multipoint Pacing CRT-D on Neurohormonal Activation.
NCT02139891 ·Status: COMPLETED ·Phase: NA
-
MPP Narrow QRS:Pilot Study on Multipoint Pacing in Patients With QRS Beetwen 100 and 130 Msec
NCT02402816 ·Status: UNKNOWN ·Phase: NA
-
Resynchronization Therapy in Young Patients With and Without CHD
NCT00208806 ·Status: COMPLETED
-
Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads
NCT01484613 ·Status: COMPLETED
-
Left Bundle Branch Area Pacing in Heart Failure Patients With Ejection Fraction Below Normal
NCT06148571 ·Status: RECRUITING
-
Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy
NCT04740554 ·Status: COMPLETED
-
Trajectory Changes of Coronary Sinus Lead Tip and Cardiac Resynchronization Therapy Outcome
NCT02340546 ·Status: COMPLETED
-
Effect of Bi-ventricular Pacing on Autonomous Nervous System
NCT00190138 ·Status: UNKNOWN ·Phase: NA
-
Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.
NCT01260402 ·Status: COMPLETED ·Phase: NA
-
Effect of His Bundle Pacing in Treatment of Slow Arrhythmia on Function of Left Atrial and Ventricle
NCT03590353 ·Status: COMPLETED ·Phase: NA
-
Effects of Preferential Left Ventricular Pacing on Ventriculoarterial Coupling and Clinical Course of Heart Failure
NCT04420065 ·Status: UNKNOWN ·Phase: NA
-
A Study of Triple-site Ventricular Pacing in Patients Who Have Not Responded to Conventional Dual Ventricular Site Cardiac Resynchronization Therapy
NCT00941850 ·Status: COMPLETED ·Phase: PHASE4
-
The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchronization Therapy With MultiPoint Pacing
NCT02782598 ·Status: COMPLETED
-
Endocardial Pacing in On-table Non-responders in Cardiac Resynchronization Therapy
NCT01193712 ·Status: WITHDRAWN ·Phase: NA
-
Left Ventricular Lead Position in Cardiac Resynchronization Therapy
NCT00748735 ·Status: COMPLETED
-
Diagnostic Electrical Cardioversion for Explaining Patient's AF and HF Symptoms
NCT07000942 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of Multi-point Pacing and Conventional CRT Through Non-invasive Hemodynamics Measurement and Global Longitudinal Strain Assessment
NCT04299360 ·Status: COMPLETED
-
Mitral Insufficiency Reduction With Biventricular Pacing
NCT01242397 ·Status: UNKNOWN ·Phase: PHASE1
-
Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundle Branch Block
NCT03803995 ·Status: COMPLETED ·Phase: NA
-
Effect Of Bioelectric Therapy On Sternal Instability In Patients With Median Sternotomy After Heart Valve Surgery
NCT04949581 ·Status: UNKNOWN ·Phase: NA
-
Postoperative Atrial Fibrillation Suppression By Nerve Stimulation
NCT03533140 ·Status: UNKNOWN ·Phase: NA